The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters

Purpose:

To find the correlation between hemogram parameters and Delta Neutrophil Index(DNI) and Serum PSA in patients presenting with the diagnosis of acute prostatitis.

Material-Metod: Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Infection Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostate Cancer Prostate Disease Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year–90 year

Sex eligibility

Male

Study type

Observational

Primary location

Basri Cakiroglu

Istanbul, 34768, Turkey (Türkiye)

About this study

Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.

WBC, neutrophil, lymphocyte, neutrophil-lymphocyte ratio, delta neutrophil index (DNI), PLT, RDW, and MPV values were determined in the Hemogram Parameters. Serum Total PSA and Free PSA values of the patients were also checked. Urine culture, urinary ultrasound, and antibiotic therapy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Acute prostatitis Male

Exclusion criteria

Prostate cancer Chronic prostatitis Other Urinary infections,

Treatment and study plan

Serum PSA,Delta Neutrophil Index(DNI),WBC

Diagnostic Test

Urine culture, prostate volume

Other names: MPV,NLR,RDW

Primary outcomes

Area Under the Plasma Concentration Versus Time Curve (AUC)

Time frame: 4 years

Sponsors and collaborators

Lead sponsor

Hisar Intercontinental Hospital

Other

Registry information

Important dates

Study start: 2018
Primary completion: 2022
Study completion: 2022
First posted: Jun 1, 2022
Registry last updated: Jun 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed